首页> 外文期刊>Hepato-gastroenterology. >Accuracy of Endorectal Endoscopic Ultrasound (EUS) for Locally Advanced Rectal Cancer (LARC) Restaging After Neoadjuvant Chemoradiotherapy (NAT): A Meta-Analysis
【24h】

Accuracy of Endorectal Endoscopic Ultrasound (EUS) for Locally Advanced Rectal Cancer (LARC) Restaging After Neoadjuvant Chemoradiotherapy (NAT): A Meta-Analysis

机译:新辅助放化疗(NAT)后局部直肠癌(LARC)内镜直肠内镜超声(EUS)的准确性:荟萃分析。

获取原文
获取原文并翻译 | 示例
           

摘要

Background/Aims: Endorectal endoscopic ultrasound (EUS) can provide accurate and reliable information for initial staging of locally advanced rectal cancer (LARC) in both the depth of rectal cancer penetration (T-stage)and regional lymph node involvement (N-stage). However, there is still no consensus about its accuracy in retagging LARC after neoadjuvant chemoradiotherapy (NAT). Methodology: In this study, we retrieved previous studies and performed a meta-analysis for assessing the accuracy of EUS for retagging of LARC after NAT. Results: It was found the accuracy of EUS for T restaging of LARC was relatively low and over-staging was common, although the accuracy for assessing T3/4 was significantly higher than T0-T2 stage. The specificity of EUS for assessing N stage was relatively high, but the sensitivity was relatively low. Conclusions: Data obtained in this study confirmed the overall accuracy of EUS is not sufficient to serve as a basis for decisions on restaging. Exploring the possible application of new techniques is necessary for better restaging.
机译:背景/目的:直肠内窥镜超声检查(EUS)可为直肠癌浸润深度(T期)和局部淋巴结受累(N期)的局部晚期直肠癌(LARC)的初始分期提供准确可靠的信息。然而,关于在新辅助放化疗后重新标记LARC的准确性仍未达成共识。方法:在这项研究中,我们检索了以前的研究并进行了荟萃分析,以评估EUS在NAT后重新标记LARC的准确性。结果:尽管评估T3 / 4的准确度明显高于T0-T2期,但发现EUS进行LARC T分期的准确性相对较低,且分期过高是常见的。 EUS评估N期的特异性较高,但敏感性较低。结论:本研究获得的数据证实EUS的整体准确性不足以作为再分期决策的基础。探索新技术的可能应用对于更好地重新分段是必要的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号